XML 11 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Feb. 29, 2024
Feb. 28, 2023
Cash flows from operating activities:    
Net income $ 7,323 $ 5,184
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 2,318 1,810
Amortization of intangible assets 2,267 2,712
Deferred income taxes (1,755) (1,253)
Stock-based compensation 2,927 2,583
Other, net 631 487
Changes in operating assets and liabilities, net of effects from acquisitions:    
(Increase) decrease in trade receivables, net (409) 460
Decrease in prepaid expenses and other assets 457 515
Decrease in accounts payable and other liabilities (682) (783)
Decrease in income taxes payable (788) (453)
Increase in deferred revenues 303 256
Net cash provided by operating activities 12,592 11,518 Close
Cash flows from investing activities:    
Purchases of marketable securities and other investments (674) (921)
Proceeds from sales and maturities of marketable securities and other investments 207 552
Acquisitions, net of cash acquired (59) (27,721)
Capital expenditures (4,068) (6,782)
Net cash used for investing activities (4,594) (34,872) Close
Cash flows from financing activities:    
Payments for repurchases of common stock (1,050) (1,150)
Proceeds from issuances of common stock 454 759
Shares repurchased for tax withholdings upon vesting of restricted stock-based awards (1,865) (1,040)
Payments of dividends to stockholders (3,289) (2,586)
Proceeds from issuances of commercial paper, net of repayments 936 1,874
Proceeds from issuances of senior notes and other borrowings, net of issuance costs 0 33,494
Repayments of senior notes and other borrowings (3,500) (21,050)
Other, net 34 49
Net cash (used for) provided by financing activities (8,280) 10,350 Close
Effect of exchange rate changes on cash and cash equivalents (2) (160) Close
Net decrease in cash and cash equivalents (284) (13,164) Close
Cash and cash equivalents at beginning of period 9,765 21,383
Cash and cash equivalents at end of period 9,481 8,219
Non-cash financing activities:    
Fair values of stock awards assumed in connection with acquisitions $ 0 $ 55